SOTAC PHARMACEUTICALS
|
SOTAC PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Profit Before Tax | ₹3.93 Cr | ₹4.69 Cr | ₹-2.06 Cr | ₹0.36 Cr |
Adjustment | ₹4.33 Cr | ₹3.43 Cr | ₹3.78 Cr | ₹1.98 Cr |
Changes In working Capital | ₹1.57 Cr | ₹0.08 Cr | ₹-1.61 Cr | ₹-2.03 Cr |
Cash Flow after changes in Working Capital | ₹9.83 Cr | ₹8.21 Cr | ₹0.11 Cr | ₹0.31 Cr |
Cash Flow from Operating Activities | ₹8.14 Cr | ₹6.35 Cr | ₹-0.31 Cr | ₹0.06 Cr |
Cash Flow from Investing Activities | ₹-12 Cr | ₹-3.52 Cr | ₹-3.23 Cr | ₹-12 Cr |
Cash Flow from Financing Activities | ₹13 Cr | ₹-2.83 Cr | ₹3.38 Cr | ₹11 Cr |
Net Cash Inflow / Outflow | ₹9.61 Cr | ₹0.00 Cr | ₹-0.16 Cr | ₹-0.29 Cr |
Opening Cash & Cash Equivalents | ₹0.08 Cr | ₹0.02 Cr | ₹0.43 Cr | ₹0.72 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹9.68 Cr | ₹0.03 Cr | ₹0.27 Cr | ₹0.43 Cr |
Compare Cashflow Statement of peers of SOTAC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOTAC PHARMACEUTICALS | ₹137.2 Cr | -1.1% | 1.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
SOTAC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOTAC PHARMACEUTICALS | -1.1% |
1.3% |
|
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses